Lobular Breast Carcinoma Clinical Trials

9 recruitingLast updated: June 17, 2026

There are 9 actively recruiting lobular breast carcinoma clinical trials across 2 countries. Studies span Phase 2, Phase 1, Not Applicable. Top locations include Middletown, New Jersey, United States, Montvale, New Jersey, United States, Harrison, New York, United States. Updated daily from ClinicalTrials.gov.


Lobular Breast Carcinoma Trials at a Glance

9 actively recruiting trials for lobular breast carcinoma are listed on ClinicalTrialsFinder across 6 cities in 2 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Middletown, Montvale, and Harrison. Lead sponsors running lobular breast carcinoma studies include Memorial Sloan Kettering Cancer Center, Istituto Oncologico Veneto IRCCS, and Blue Earth Diagnostics.

Browse lobular breast carcinoma trials by phase

Treatments under study

About Lobular Breast Carcinoma Clinical Trials

Looking for clinical trials for Lobular Breast Carcinoma? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lobular Breast Carcinoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lobular Breast Carcinoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 2

18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer

Breast Cancer FemaleLobular Breast CarcinomaPET/MRI+2 more
Università Vita-Salute San Raffaele119 enrolled1 locationNCT05982496
Recruiting
Phase 2

A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer

Breast CancerHER2-Negative Breast CarcinomaHER2-negative Breast Cancer+2 more
Memorial Sloan Kettering Cancer Center176 enrolled7 locationsNCT07483307
Recruiting

Negative Hormone Receptor and APOcrine Lobular Invasive Breast Cancer

Lobular Breast Carcinoma
Istituto Oncologico Veneto IRCCS250 enrolled1 locationNCT07613151
Recruiting
Phase 2

Biomarkers to Detect Endocrine Therapy Resistance

Breast CancerMetastatic CancerLobular Breast Carcinoma
University of Wisconsin, Madison8 enrolled1 locationNCT06067503
Recruiting
Not Applicable

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Pancreatic CancerSarcomaMelanoma+12 more
Memorial Sloan Kettering Cancer Center26 enrolled7 locationsNCT05837767
Recruiting
Phase 1Phase 2

[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

Colorectal, CancerGastric CancerPancreatic Ductal Adenocarcinoma+2 more
Blue Earth Diagnostics71 enrolled1 locationNCT07432633
Recruiting
Phase 1

[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)

Metastatic Lobular Breast Carcinoma
University of California, Davis30 enrolled1 locationNCT07020806
Recruiting

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

Metastatic Breast CancerLobular Breast Carcinoma
University of California, San Francisco12 enrolled4 locationsNCT05964504
Recruiting

A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer

Breast CancerBreast CarcinomaMetastatic Breast Cancer+3 more
Memorial Sloan Kettering Cancer Center30 enrolled7 locationsNCT06557148